TANG CAPITAL MANAGEMENT LLC - Q3 2015 holdings

$271 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 8 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 33.3% .

 Value Shares↓ Weighting
HRTX  HERON THERAPEUTICS INC$126,657,000
-21.7%
5,190,8370.0%46.70%
-4.8%
LJPC BuyLA JOLLA PHARMACEUTICAL CO$81,007,000
+24.0%
2,914,970
+9.4%
29.87%
+50.7%
OPK NewOPKO HEALTH INC$20,815,0002,475,000
+100.0%
7.68%
BMRN  BIOMARIN PHARMACEUTICAL INC$19,200,000
-23.0%
182,3000.0%7.08%
-6.4%
 OPKO HEALTH INCdebt 3.0% 2/1/33$18,247,000
-44.9%
14,000,0000.0%6.73%
-33.1%
 MERRIMACK PHARMACEUTICALS INCnote 4.5% 7/15/20$5,259,000
-28.2%
3,500,0000.0%1.94%
-12.8%
BRLI ExitBIO-REFERENCE LABS INC$0-900,000
-100.0%
-11.26%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERON THERAPEUTICS INC37Q3 202355.0%
LA JOLLA PHARMACEUTICAL CO34Q2 202237.1%
ROCKET PHARMACEUTICALS INC20Q3 202331.6%
BIOMARIN PHARMACEUTICAL INC18Q3 201712.1%
ODONATE THERAPEUTICS INC17Q4 202169.8%
ANAPTYSBIO INC16Q3 202318.4%
COHERUS BIOSCIENCES INC15Q3 20232.7%
EQUILLIUM INC13Q3 20231.2%
RELMADA THERAPEUTICS INC12Q4 20226.2%
MIRATI THERAPEUTICS INC11Q3 202310.9%

View TANG CAPITAL MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
42024-02-14
42024-02-02
42023-12-18
13F-HR2023-11-14
42023-10-13
13F-HR2023-08-14
32023-06-01
42023-06-01
42023-05-30

View TANG CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export TANG CAPITAL MANAGEMENT LLC's holdings